Electroretinography (ERG) Monitoring for Vigabatrin Visual Toxicity (The Pros)

Update item information
Identifier 20210223_nanos_controversiespediatricno1_01-slidesa
Title Electroretinography (ERG) Monitoring for Vigabatrin Visual Toxicity (The Pros)
Creator Steven F. Stasheff, MD , Ph
Subject Vigabatrin; Toxicity; Vision Loss; Electroretinography (ERG); Epilepsy
Description Eleven years ago, FDA approval of vigabatrin treatment for complex and refractory childhood epilepsy in the United States added substantially to previous experience in Europe, Canada and elsewhere. This experience has revealed both its utility in a wider variety of complex, refractory seizure disorders and its retina to the optic nerves and central nervous system (CNS) structures. Basic research has pointed towards several underlying pathophysiologic mechanisms of visual loss, which may interact variably with patients' underlying neurodevelopmental diseases.
Relation is Part of NANOS Annual Meeting 2021: Controversies in Pediatric Neuro-Ophthalmology
Contributor Primary Steven F. Stasheff, MD , Ph
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date 2021-02
Type Text
Format application/pdf
Source 2021 North American Neuro-Ophthalmology Society Annual Meeting
Rights Management Copyright 2021. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Language eng
ARK ark:/87278/s68m37zs
Setname ehsl_novel_nam
Date Created 2021-04-29
Date Modified 2021-05-06
ID 1694057
Reference URL https://collections.lib.utah.edu/ark:/87278/s68m37zs